ACADIA Pharmaceuticals, Inc. (NASDAQ:ACAD)

CAPS Rating: 3 out of 5

The Company is a biopharmaceutical company focused on the discovery, development, and commercialization of small molecule drugs for the treatment of central nervous system disorders.

Recs

0
Player Avatar mastiff5 (51.03) Submitted: 6/10/2007 10:29:07 PM : Outperform Start Price: $14.49 ACAD Score: -83.38

good time for pharmsss.

Featured Broker Partners


Advertisement